Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 154Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Complera/Eviplera

02 2Stribild

PharmaCompass

01

Brand Name : Complera/Eviplera

Tenofovir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Complera/Eviplera

arrow
Antibody Engineering
Not Confirmed

Tenofovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 200

2021 Revenue in Millions : 258

Growth (%) : -22

blank

02

Brand Name : Stribild

Tenofovir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stribild

arrow
Antibody Engineering
Not Confirmed

Tenofovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2022 Revenue in Millions : 127

2021 Revenue in Millions : 189

Growth (%) : -33

blank

03

Brand Name : Stribild

Tenofovir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Stribild

arrow
Antibody Engineering
Not Confirmed

Tenofovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 101

2022 Revenue in Millions : 127

Growth (%) : -20

blank

04

Brand Name : Complera/Eviplera

Tenofovir

arrow
Antibody Engineering
Not Confirmed

Brand Name : Complera/Eviplera

arrow
Antibody Engineering
Not Confirmed

Tenofovir

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2023 Revenue in Millions : 129

2022 Revenue in Millions : 200

Growth (%) : -36

blank